Efficacy and safety of prolonged 3-year telbivudine treatment in patients with chronic hepatitis B

• المؤلفون الرئيسيون: Edward J. Gane, Yuming Wang, Yun Fan Liaw, Jinlin Hou, Satawat Thongsawat, Mobin Wan, Young M. Moon, Jidong Jia, You C. Chao, Junqi Niu, Nancy Leung, Didier Samuel, Chao Wei Hsu, Weibin Bao, Patricia Lopez, Claudio Avila
• التنسيق: دورية
• منشور في: 2018
• الموضوعات: Medicine
• الوصول للمادة أونلاين: https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=79953315167&origin=inward; http://cmuir.cmu.ac.th/jspui/handle/6653943832/50242
• المؤسسة: Chiang Mai University

Background: In the GLOBE trial, telbivudine demonstrated superior efficacy to lamivudine at 2 years in patients with chronic hepatitis B (CHB). Aims: To investigate the long-term efficacy and safety of telbivudine in the telbivudine-treated cohort from the GLOBE trial. Methods: Virological and bioch...